4-Eppedo 50mg Injection

Epirubicin (50mg) Primary uses of : Ovarian cancer, Breast cancer, Non-small cell lung cancer
Manufacturer: Miracalus Pharma Pvt Ltd
₹ 2,200.00 incl tax
Expert advice for 4-Eppedo Injection Use appropriate contraception during treatment with epirubicin, if you are women of childbearing potential. Male patients should not to father a child during and for 6 months after stopping epirubicin treatment. Inform you doctor if you have or had suffered problems with your heart, liver or if you have severe infection such as urinary infection. Do not drink fluids for 12 hours before the treatment if epirubicin is to be used in the bladder. Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Composition Epirubicin (50mg)
Potentially Unsafe With Alcohol
Side Effect Common Nausea, Vomiting, Loss of appetite, Low blood platelets, Hair loss, Anemia (low number of red blood cells), Diarrhoea, Discoloration of urine, Mucosal inflammation, Stomatitis (Inflammation of the mouth), Febrile neutropenia, Decreased white blood cell count (neutrophils).
How to works How 4-Eppedo Injection works 4-Eppedo 50mg Injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.